Matthew G. Hurd - MergerLinks

PublicAcquisitionMerger

target

Monsanto Co

bidder

Bayer

£48,040m

133 dealmakers

PublicAcquisition

target

The Spectranetics Corporation

bidder

Philips

value n/a

9 dealmakers

PrivateAcquisitionMajority

Machinery: Industrial

target

Esco Corporation

bidder

Weir Group

value n/a

22 dealmakers

Germany

Farming Fishing Ranching and Plantations

PrivateAcquisitionMajority

target

Bayer Crop Science Business

bidder

Basf

£1,480m

21 dealmakers

Medical Supplies

PrivateAcquisition

target

Respiratory Technologies

bidder

Philips

value n/a

6 dealmakers

PublicAcquisitionMergerMajorityCross Border

Semiconductors

target

Versum Materials

bidder

Merck Kgaa

£4,984m

94 dealmakers

AcquisitionPrivateMajority

IT Services: Other

target

Carestream Health (healthcare Information Systems)

bidder

Philips

value n/a

24 dealmakers

AcquisitionPublicMergerMajorityPrivatisationDomestic

target

Genomic Health

bidder

Exact Sciences

£2,260m

43 dealmakers

Germany

Medical Supplies

MajorityPrivateAcquisition

target

Bayer (animal Health Unit)

bidder

Elanco Animal Health

£6,261m

78 dealmakers

MajorityAcquisitionPrivateDomestic

target

OTEZLA

bidder

Amgen

£10,900m

45 dealmakers

PrivateMajorityAcquisitionCross Border

Electrical Components

target

Cooper Lighting

bidder

SIGNIFY

£1,043m

23 dealmakers

PublicAcquisitionMajorityTender Offer

target

The Medicines Company

bidder

Novartis

£7,553m

43 dealmakers

AcquisitionPrivateMajority

IT Services: Other

target

QUORUM

bidder

CONSENSYS

value n/a

11 dealmakers

PrivateDomesticMajorityAcquisition

Engineering Consulting

target

Weir Oil & Gas

bidder

CATERPILLAR

£312m

25 dealmakers

Cross BorderMajorityAcquisitionPublicTender Offer

target

Biotelemetry

bidder

Philips

£2,062m

40 dealmakers

AcquisitionMajorityDomesticPrivate

target

Agios Pharmaceuticals (oncology Business)

bidder

Servier International

£1,500m

28 dealmakers

Electronic Components and Equipment

DomesticAcquisitionPrivateMajority

target

Tripp Lite

bidder

Eaton Corporation

£1,205m

38 dealmakers

AcquisitionDomesticPublicMajorityPrivatisation

Specialty Chemicals

target

W. R. Grace & Co

bidder

Standard Industries

£5,042m

52 dealmakers

Canada

Chemicals and Synthetic Fibres

Cross BorderMajorityAcquisitionPrivate

target

Ft Synthetics

bidder

GAF

value n/a

38 dealmakers

AcquisitionPrivate EquityMinorityVenture CapitalCross BorderPrivate

Software

target

CONSENSYS

bidder

Defiance Capital

£148m

11 dealmakers

MajorityAcquisitionPublicCross BorderPrivatisation

Chemicals: Diversified

target

Gcp Applied Technologies

bidder

Compagnie De Saint-gobain

£1,736m

53 dealmakers

Austria

Building Materials: Other

Cross BorderPrivateMajorityAcquisition

target

FLUENCE

bidder

SIGNIFY

£205m

28 dealmakers

Venture CapitalAcquisitionPrivate EquityPrivateMinorityCross Border

Software

target

CONSENSYS

bidder

Parafi Capital

£345m

28 dealmakers

AcquisitionDomesticMajorityPublic

target

Chemocentryx

bidder

Amgen

£3,043m

28 dealmakers

AcquisitionPublicMajorityDomestic

target

Global Blood Therapeutics

bidder

Pfizer

£4,472m

52 dealmakers

MergerAcquisitionMajorityCross BorderPublic

target

Aerie Pharmaceuticals

bidder

Alcon

£650m

58 dealmakers

AcquisitionMajorityDomesticTender OfferPublic

target

ABIOMED

bidder

Johnson & Johnson

£14,391m

53 dealmakers

AcquisitionCross BorderPrivate EquityMinorityPrivate

Software

target

CONSENSYS

bidder

Samsung Venture Investment Corporation

value n/a

7 dealmakers

MajorityDomesticAcquisitionPublic

target

Seagen

bidder

Pfizer

£35,705m

66 dealmakers

AcquisitionDomesticMajorityPublic

target

EQRX

bidder

Revolution Medicines

£900m

109 dealmakers

MajorityPrivate EquityDomesticAcquisitionPublicMerger

Health Care Services

target

Tabula Rasa Healthcare

bidder

Exactcare Pharmacy

£446m

31 dealmakers

AcquisitionCross BorderMajorityPublic

target

Intercept Pharmaceuticals

bidder

Alfasigma

£649m

31 dealmakers

MergerPublicAcquisitionDomesticMajority

target

Karuna Therapeutics

bidder

Bristol Myers Squibb Company

£11,026m

54 dealmakers